New Zealand close to Eltroxin alternative
This article was originally published in Scrip
Executive Summary
New Zealand's pharmaceutical management agency Pharmac has begun a consultation on a proposal to subsidise a possible alternative to GlaxoSmithKline's thyroid medication Eltroxin (levothyroxine) in the country.